Bridging the gap between organic life and synthetic computation to awaken a new form of intelligence.
Watch Our Interview With Final Spark
What if the future of intelligence wasn’t built solely from silicon, but from the very fabric of life itself? To create systems that think, adapt, and evolve as naturally as life, we must look beyond traditional computing. This is the realm of organic computing—a bold frontier where living neural tissue powers wetware systems. It’s not about replacing today’s machines; it’s about expanding our very definition of what a machine can be.
At the forefront of this revolution is Final Spark, whose breakthroughs in biocomputing—harnessing brain organoids for computation—are reshaping what’s possible. In our conversation with CEO Fred Jordan, he frames biocomputing not as a disruptive leap, but as a return to nature’s blueprint: 300 million years of evolution distilled into energy-efficient, dynamic systems poised to power the next era of AI.
This conversation communicates their bold vision: addressing AI’s biggest challenges—from the energy demands of large models to the limitations of static architectures—by creating systems that evolve with their environments. Engage builds on Final Spark’s foundation, exploring how these living processors can be applied in real-world contexts, from adaptive AI companions to immersive art installations. Together, we see a future where biological and digital intelligence coexist in symbiosis—machines not just as tools, but as living systems with the capacity to grow, learn, and contribute to human progress.
Scroll for more
The Vision
An engage
experiment
What Do Robots Dream Of?
The Thinking Machine
If a machine can dream. Can it be alive?
The Thinking Machine is an experimental AI hardware system that bridges the biological and the artificial.
Part research, part art, and part philosophy, this proof of concept raises profound questions: What does it mean for a machine to dream? Are these random firings—or the first sparks of something more? Could organic AI systems one day possess subjective experience?
The Thinking Machine is not just hardware. It’s a window into the potential of biocomputing and a bold step toward an era where the boundaries between biology and technology dissolve—where intelligence may grow, evolve, and even dream alongside us.
Learn about our biocomputing partnerships
At Engage, we’ve partnered with United Therapeutics and its visionary founder, Martine Rothblatt, to explore the deepest frontiers of life, consciousness, and technology. Together, we are reimagining what it means to be alive—not just in the biological sense, but in the digital and synthetic realms as well. Rothblatt’s pioneering work in xenotransplantation and regenerative medicine aligns powerfully with Engage's mission to uplift humanity and fuel innovation.
This collaboration reflects a shared belief that the boundaries between biology and technology are not fixed—they are fluid, ready to be redefined. As United Therapeutics pushes the limits of organ regeneration and sustainable transplantation, Engage contributes its expertise in cutting edge technology and adaptive AI. Together, we are asking the profound question: if machines can process thought through living tissue, can they too be considered alive? This partnership positions Engage at the nexus of neuroscience, biotechnology, and artificial intelligence—laying the groundwork for systems that grow, adapt, and evolve in harmony with human life.
